SCHEMBL4446285

SCHEMBL4446285

Cc1cccc(/C=C/CBr)c1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 1/20 0.51
PTGER4 P35408 1/20 0.51
PTGER3 P43115 1/20 0.51
PTGER2 P43116 1/20 0.51
ALDH1A1 P00352 5/20 0.46
TRPA1 O75762 2/20 0.42
KDM4E B2RXH2 5/20 0.39
MAPT P10636 3/20 0.39
GAA P10253 2/20 0.39
HSD17B10 Q99714 2/20 0.39
POLB P06746 2/20 0.39
HTT P42858 2/20 0.39
PSMD14 O00487 1/20 0.39
USP2 O75604 1/20 0.39
ALOX12 P18054 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
HPGD P15428 3/20 0.38
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4446287 1.00 PTGER1 (0.51) PTGER1PTGER4PTGER3PTGER2ALDH1A1
SCHEMBL16713040 0.83 PTGER1 (0.52) PTGER1PTGER4PTGER3PTGER2ALDH1A1
SCHEMBL16713042 0.83 PTGER1 (0.52) PTGER1PTGER4PTGER3PTGER2ALDH1A1
SCHEMBL11051471 0.80 ALDH1A1 (0.46) PTGER1PTGER4PTGER3PTGER2ALDH1A1
SCHEMBL11801745 0.80 ALDH1A1 (0.46) PTGER1PTGER4PTGER3PTGER2ALDH1A1
SCHEMBL17666841 0.77 PTGER1 (0.48) PTGER1PTGER4PTGER3PTGER2ALDH1A1
SCHEMBL2158538 0.76 ALDH1A1 (0.54) PTGER1PTGER4PTGER3PTGER2ALDH1A1
SCHEMBL2158535 0.76 ALDH1A1 (0.54) PTGER1PTGER4PTGER3PTGER2ALDH1A1
SCHEMBL11150484 0.75 PTGER1 (0.46) PTGER1PTGER4PTGER3PTGER2ALDH1A1
SCHEMBL4451890 0.73 ALDH1A1 (0.49) PTGER1PTGER4PTGER3PTGER2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629494-B2 Process for producing cyclopropylphenol derivative MITSUI CHEMICALS AGRO, INC. (JP) 2009-12-08 US claimed
US-20090054681-A1 Production Process of cyclopropylphenol derivatives SANKYO AGRO COMPANY, LIMITED (JP) 2009-02-26 US claimed
EP-1880987-A1 PROCESS FOR PRODUCING CYCLOPROPYLPHENOL DERIVATIVE Sankyo Agro Company, Limited (JP) 2008-01-23 EP claimed
CN-101151234-B Process for producing cyclopropylphenol derivative SANKYO AGRO CO LTD 2011-06-15 CN disclosed
US-7629494-B2 Process for producing cyclopropylphenol derivative MITSUI CHEMICALS AGRO, INC. (JP) 2009-12-08 US disclosed
US-20090054681-A1 Production Process of cyclopropylphenol derivatives SANKYO AGRO COMPANY, LIMITED (JP) 2009-02-26 US disclosed
CN-101151234-A Process for producing cyclopropylphenol derivative SANKYO AGRO CO LTD (JP) 2008-03-26 CN disclosed
EP-1880987-A1 PROCESS FOR PRODUCING CYCLOPROPYLPHENOL DERIVATIVE Sankyo Agro Company, Limited (JP) 2008-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054681-A1 Production Process of cyclopropylphenol derivatives CBR3, CYP4X1, CYP4A11 PTGER1 2136/4885PTGER4 774/4885PTGER3 580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.